Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cystic Tumors of Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 0 results

Not applicableLooking for participantsNCT07117045
What this trial is testing

Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

Who this might be right for
Pancreatic CancerIntraductal Papillary Mucinous NeoplasmHigh-grade Pancreatic Intraepithelial Neoplasia+2 more
Changhai Hospital 400,000
Not applicableStudy completedNCT03578445
What this trial is testing

Utility of EUS-guided Microbiopsies in Pancreatic Cystic Lesions

Who this might be right for
Pancreatic CystIPMNMucinous Cyst+1 more
Herlev Hospital 101
Not applicableStudy completedNCT03352037
What this trial is testing

18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study

Who this might be right for
Pancreatic Cystic Neoplasms
University Health Network, Toronto 11
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Looking for participantsNCT07166601
What this trial is testing

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 77